The described in vitro assay successfully measures measles-specific cell-mediated immunity, which may help evaluate normal hosts and those predisposed to subacute sclerosing panencephalitis.
Answers are grounded in this paper and cite their sources.
Assay detects measles-specific cell-mediated immunity in seropositive individuals with disease history; leaves open validation for SSPE risk assessment.
An in vitro lymphocyte-mediated cytotoxicity assay of cell-mediated immunity to measles virus is described that uses tissue culture lines persistently infected with measles virus. Morphologic and 51Cr-release methods were used to measure lymphocyte reactivity; they gave comparable results. Significant measles-specific cytotoxicity was observed only with lymphocytes from measles-seropositive individuals with prior histories of measles; no reactivity was demonstrable with lymphocytes from seronegative individuals and two seropositive adults with negative histories of measles. The capacity to measure measles-specific cell-mediated immunity may provide useful information in the normal host as well as an explanation for the abnormal reactivity of the host predisposed to subacute sclerosing panencephalitis.
No takes yet. Share an insight, caveat, or question.
Labowskie et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: